Selecta Biosciences (SELB) Tops Q1 EPS by 34c

Selecta Biosciences (NASDAQ: SELB) reported Q1 EPS of $0.23, $0.34 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $34 million versus the consensus estimate of $13.12 million.

For earnings history and earnings-related data on Selecta Biosciences (SELB) click here.

You May Also Be Interested In

• BofA sees an "enhanced buying opportunity" in this memory stock
• Pinnacle West Capital (PNW) Misses Q2 EPS by 2c
• Albany International (AIN) Tops Q2 EPS by 11c ; Offers Guidance